Skip to main content

Abstract

Hemodiafiltration is a form of renal replacement therapy which employs convection and diffusion to enhance the clearance of larger uremic solutes which are not adequately removed by conventional low-flux hemodialysis. Most modern dialysis machines are able to deliver hemodiafiltration. The main limiting factor that prevents its widespread implementation is the requirement for dialysis units to be capable of producing large quantities of ultrapure dialysis fluid. The benefits of hemodiafiltration include better hemodynamic stability and enhanced clearance of middle molecules such as ß2-microglobulin, especially in patients without residual kidney function. There may be a survival advantage with hemodiafiltration particularly when delivering high convective volumes although this requires confirmation in future clinical trials. Hemodiafiltration is a safe and effective mode of renal replacement therapy which offers some advantages over conventional hemodialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Babb AL, Popovich RP, Christopher TG, Scribner BH. The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs. 1971;17:81–91.

    CAS  PubMed  Google Scholar 

  2. Henderson LW, Besarab A, Michaels A, Bluemle LW. Blood purification by ultrafiltration and fluid replacement (diafiltration). Hemodial Int. 2004;8(1):10–8.

    Article  CAS  PubMed  Google Scholar 

  3. Leypoldt JK. Solute fluxes in different treatment modalities. Nephrol Dial Transpl. 2000;15(Suppl 1):3–9.

    Article  CAS  Google Scholar 

  4. Leber HW, Wizemann V, Goubeaud G, Rawer P, Schütterle G. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Clin Nephrol. 1978;9(3):115–21.

    CAS  PubMed  Google Scholar 

  5. Wizemann V, Rawer P, Schütterle G. Ultrashort hemodiafiltration: long term efficiency and hemodynamic tolerance. Proc Eur Dial Transplant Assoc. 1983;19:175–81.

    CAS  PubMed  Google Scholar 

  6. Wizemann V, Kramer W. Short-term dialysis—long-term complications. Ten years experience with short-duration renal replacement therapy. Blood Purif. 1987;5(4):193–201.

    Article  CAS  PubMed  Google Scholar 

  7. Tattersall J. Clearance of beta-2-microglobulin and middle molecules in hemodiafiltration. Contrib Nephrol. 2007;158:201–9.

    Article  CAS  PubMed  Google Scholar 

  8. Henderson LW. The birth of hemodiafiltration. Contrib Nephrol. 2007;158:1–8.

    Article  CAS  PubMed  Google Scholar 

  9. Roy T, Ahrenholz P, Falkenhagen D, Klinkmann H. Volumetrically controlled ultrafiltration. Current experiences and future prospects. Int J Artif Organs. 1982;5(3):131–5.

    CAS  PubMed  Google Scholar 

  10. Ronco C, Fabris A, Feriani M, Chiaramonte S, Brendolan A, Bragantini L, et al. Technical and clinical evaluation of a new system for ultrafiltration control during hemodialysis. ASAIO Trans. 34(3):613–6.

    Google Scholar 

  11. Henderson LW, Beans E. Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int. 1978;14(5):522–5.

    Article  CAS  PubMed  Google Scholar 

  12. Henderson LW, Sanfelippo ML, Beans E. “On line” preparation of sterile pyrogen-free electrolyte solution. Trans Am Soc Artif Intern Organs. 1978;24:465–7.

    CAS  PubMed  Google Scholar 

  13. Ronco C, Ghezzi PM, Brendolan A, Crepaldi C, La Greca G. The hemodialysis system : basic mechanisms of water and solute transport in extracorporeal renal replacement therapies. Nephrol Dial Transpl. 1998;13(Suppl 6):3–9.

    Article  CAS  Google Scholar 

  14. Tattersall JE, Ward RA. Online hemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transpl. 2013;28(3):542–50.

    Article  CAS  Google Scholar 

  15. van der Weerd NC, Penne EL, van den Dorpel MA, Grooteman MPC, Nube MJ, Bots ML, et al. Hemodiafiltration: promise for the future? Nephrol Dial Transpl. 2008;23(2):438–43.

    Article  Google Scholar 

  16. Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G. Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note. Kidney Int. 1998;54(3):979–85.

    Article  CAS  PubMed  Google Scholar 

  17. Krieter DH, Falkenhain S, Chalabi L, Collins G, Lemke H-D, Canaud B. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration. Kidney Int. 2005;67(1):349–56.

    Article  PubMed  Google Scholar 

  18. Bowry S, Canaud B. Achieving high convective volumes in on-line hemodiafiltration. Blood Purif. 2013;35(Suppl 1):23–8.

    Article  PubMed  Google Scholar 

  19. Canaud B, Chenine L, Renaud S, Leray H. Optimal therapeutic conditions for online hemodiafiltration. Contrib Nephrol. 2011;168:28–38.

    Article  PubMed  Google Scholar 

  20. Ledebo I. On-line preparation of solutions for dialysis: practical aspects versus safety and regulations. J Am Soc Nephrol. 2002;13(Suppl 1):S78–83.

    CAS  PubMed  Google Scholar 

  21. Grooteman MPC, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AHA, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23(6):1087–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online hemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transpl. 2013;28(1):192–202.

    Article  Google Scholar 

  23. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487–97.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wang AY, Ninomiya T, Al-Kahwa A, Perkovic V, Gallagher MP, Hawley C, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials. Am J Kidney Dis. 2014;63(6):968–78.

    Article  PubMed  Google Scholar 

  25. Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, et al. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis. 2014;63(6):954–67.

    Article  PubMed  Google Scholar 

  26. Susantitaphong P, Jaber BL. Understanding discordant meta-analyses of convective dialytic therapies for chronic kidney failure. Am J Kidney Dis. 2014;63(6):888–91.

    Article  PubMed  Google Scholar 

  27. Fry AC, Singh DK, Chandna SM, Farrington K. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux hemodialysis and on-line hemodiafiltration. Blood Purif. 2007;25(3):295–302.

    Article  CAS  PubMed  Google Scholar 

  28. Penne EL, van der Weerd NC, Blankestijn PJ, van den Dorpel MA, Grooteman MPC, Nubé MJ, et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol. 2010;5(1):80–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Farrington K, Davenport A. The ESHOL study: hemodiafiltration improves survival-but how? Kidney Int. 2013;83(6):979–81.

    Article  PubMed  Google Scholar 

  30. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006;17(2):546–55.

    Article  CAS  PubMed  Google Scholar 

  31. Okuno S, Ishimura E, Kohno K, Fujino-Katoh Y, Maeno Y, Yamakawa T, et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2009;24(2):571–7.

    Article  CAS  PubMed  Google Scholar 

  32. Wizemann V, Lotz C, Techert F, Uthoff S. On-line hemodiafiltration versus low-flux hemodialysis. A prospective randomized study. Nephrol Dial Transpl. 2000;15(Suppl 1):43–8.

    Article  Google Scholar 

  33. Schiffl H. Prospective randomized cross-over long-term comparison of online hemodiafiltration and ultrapure high-flux hemodialysis. Eur J Med Res. 2007;12(1):26–33.

    CAS  PubMed  Google Scholar 

  34. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian cooperative dialysis study group. Kidney Int. 1996;50(4):1293–302.

    Article  CAS  PubMed  Google Scholar 

  35. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol. 2000;11(12):2344–50.

    CAS  PubMed  Google Scholar 

  36. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D’Haenens P. On-line hemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant. 2000;15(Suppl 1):49–54.

    Article  PubMed  Google Scholar 

  37. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15(4):1061–70.

    Article  PubMed  Google Scholar 

  38. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental hemodialysis despite reduced dialysis dose. Nephrol Dial Transplant. 2009;24(8):2502–10.

    Article  PubMed  Google Scholar 

  39. Babb AL, Ahmad S, Bergström J, Scribner BH. The middle molecule hypothesis in perspective. Am J Kidney Dis. 1981;1(1):46–50.

    Article  CAS  PubMed  Google Scholar 

  40. Bargman J, Golper T. The importance of residual renal function for patients on dialysis. Nephrol Dial Transpl. 2005;20:671–3.

    Article  Google Scholar 

  41. Hsu P-Y, Lin C-L, Yu C-C, Chien C-C, Hsiau T-G, Sun T-H, et al. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients-a prospective cross-over study. J Nephrol. 17(5):693–700.

    Google Scholar 

  42. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in hemodialysis patients. Nephrol Dial Transpl. 2000;15(8):1207–11.

    Article  CAS  Google Scholar 

  43. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009;4(12):1944–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, et al. Chronic inflammation and mortality in hemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transpl. 2008;23(7):2337–43.

    Article  Google Scholar 

  45. Den Hoedt CH, Bots ML, Grooteman MPC, van der Weerd NC, Mazairac AHA, Penne EL, et al. Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis. Kidney Int. 2014;86(2):423–32.

    Article  CAS  PubMed  Google Scholar 

  46. Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010;21(10):1798–807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Donauer J, Schweiger C, Rumberger B, Krumme B, Böhler J. Reduction of hypotensive side effects during online-hemodiafiltration and low temperature hemodialysis. Nephrol Dial Transpl. 2003;18(8):1616–22.

    Article  Google Scholar 

  48. Jansen MAM, Hart AAM, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62(3):1046–53.

    Article  PubMed  Google Scholar 

  49. Penne EL, Visser L, van den Dorpel MA, van der Weerd NC, Mazairac AHA, van Jaarsveld BC, et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice. Kidney Int. 2009;76(6):665–72.

    Article  CAS  PubMed  Google Scholar 

  50. McBrien KA, Manns BJ. Hemodiafiltration: not effective or cost-effective compared with hemodialysis. Nephrol Dial Transplant. 2013;28(7):1630–3; discussion 1633.

    Article  PubMed  Google Scholar 

  51. Oates T, Cross J, Davenport A. Cost comparison of online hemodiafiltration with high-flux hemodialysis. J Nephrol. 25(2):192–7.

    Google Scholar 

  52. Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, et al. Change from conventional hemodiafiltration to on-line hemodiafiltration. Nephrol Dial Transpl. 1999;14(5):1202–7.

    Article  CAS  Google Scholar 

  53. Eiselt J, Racek J, Opatrny K. The effect of hemodialysis and acetate-free biofiltration on anemia. Int J Artif Organs. 2000;23(3):173–80.

    CAS  PubMed  Google Scholar 

  54. Lin CL, Huang CC, Chang CT, Wu MS, Hung CC, Chien CC, et al. Clinical improvement by increased frequency of on-line hemodialfiltration. Ren Fail. 2001;23(2):193–206.

    Article  CAS  PubMed  Google Scholar 

  55. Vinhas J, Vaz Á, Barreto C, Assunção J. Survival advantage of patients on hemodiafiltration is independent of dialysis dose and patient characteristics: data from a single centre. Port J Nephrol Hypert. 2007;21(4):287–92.

    Google Scholar 

  56. Spalding EM, Pandya P, Farrington K. Effect of high haematocrit on the efficiency of high-flux dialysis therapies. Nephron Clin Pract. 2008;110(2):c86–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ken Farrington BSc, MB ChB, MD, FRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Wong, J., Sridharan, S., Greenwood, R., Farrington, K. (2016). Hemodiafiltration. In: Magee, C., Tucker, J., Singh, A. (eds) Core Concepts in Dialysis and Continuous Therapies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7657-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7657-4_23

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7655-0

  • Online ISBN: 978-1-4899-7657-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics